Phobia
13
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
7.7%
1 terminated out of 13 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
Unconscious Reduction of Fear Through Decoded Neuro-Reinforcement
Treating Phobia With Multivoxel Neuro-reinforcement
TMS Augmented Exposure Therapy
Psychotherapy of Anxiety Disorders With Noninvasive Brain Stimulation - Using Virtual Reality
Improving Access to Child Anxiety Treatment
Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety
Virtual Reality Exposure Therapy in the Intensive Treatment of Social Anxiety Disorder
TMS and Exposure Therapy
Efficacy of Targeted Intervention for Topical Steroid Phobia.
Biobehavioral Correlates of Acute Phobic Fear
Neuroimaging of Pavlovian Fear Conditioning Processes in Patients With Pathological Anxiety
Cortisol in the Treatment of Phobias